Burford's Joshua Harris quoted on patents in Reuters
- Patent & IP
Reuters reports on how generic drugmakers Teva and Sandoz are making a major push to biosimilars, quoting Burford's Joshua Harris as an expert on the subject.
Harris, a Senior Vice President with expertise in pharmaceutical patents, said that "'Creating the only biosimilar in a particular market for a particular drug could be a win," while also adding that it would be "a rare situation."
